Decreased dopamine D2 receptor binding in the anterior cingulate cortex in schizophrenia

Archives of General Psychiatry
Tetsuya SuharaLars Farde


The clinical efficacy of dopamine D2 receptor antagonism on the psychotic symptoms of schizophrenia has been widely demonstrated. However, most in vivo imaging studies have not been able to detect significant changes in striatal D2 receptors in schizophrenia. On the other hand, a number of studies have reported abnormalities in the cerebral cortex of schizophrenia. The aim of this study was to examine the extrastriatal D2 receptors of patients with schizophrenia. Eleven drug-naive male patients with schizophrenia were examined with positron emission tomography using carbon 11-labeled FLB 457. Symptoms were assessed using the Brief Psychiatric Rating Scale. Eighteen healthy controls were used for comparison. Region-of-interest analysis was performed using the reference tissue method, and binding potential (BP) was used for the index of dopamine D2 receptor binding. The BP value was significantly lower, by about 12.5%, in the anterior cingulate cortex in drug-naive patients with schizophrenia than in healthy controls. A significant negative correlation was observed between BP in the anterior cingulate cortex and the positive symptom score on Brief Psychiatric Rating Scale. The lower BP values indicate fewer D2 receptors in the an...Continue Reading


Dec 24, 2002·Proceedings of the National Academy of Sciences of the United States of America·Phil Ok KohMichael S Lidow
Jul 17, 2014·The British Journal of Psychiatry : the Journal of Mental Science·Joseph KambeitzOliver D Howes
Dec 4, 2004·Psychopharmacology·Ellen R A de BruijnBernard G C Sabbe
Mar 28, 2009·Schizophrenia Bulletin·Oliver D Howes, Shitij Kapur
May 22, 2009·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Nelson K B TotahBita Moghaddam
Aug 21, 2009·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Daniel Paul Eisenberg, Karen Faith Berman
Sep 21, 2007·Current Psychiatry Reports·Mitsuru Toda, Anissa Abi-Dargham
Jan 19, 2011·Imaging in Medicine·Judy L ThompsonAnissa Abi-Dargham
Mar 9, 2004·Journal of Psychiatric Research·Alan T BatesElton T C Ngan
Nov 22, 2011·The Psychiatric Quarterly·Sébastien UrbenLaurent Holzer
Aug 3, 2007·International Review of Psychiatry·E M MeisenzahlH-J Möller
Jan 23, 2013·Neurobiology of Disease·Saurav SeshadriAkira Sawa
Apr 3, 2012·Nuclear Medicine and Biology·Yuan-Ruei HuangChia-Chieh Chen
Apr 8, 2011·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Iluminada CorripioEnric Alvarez
Jun 30, 2009·Neuroscience and Biobehavioral Reviews·Heike TostAndreas Meyer-Lindenberg
Sep 22, 2005·Clinical and Experimental Pharmacology & Physiology·Alexandra E Rehn, Sandra M Rees
Jun 21, 2006·Synapse·Karen L BaracskayJames H Meador-Woodruff
Jan 5, 2011·CNS Neuroscience & Therapeutics·Jussi Hirvonen, Jarmo Hietala
Jan 22, 2010·Journal of Neurochemistry·Emma Perez-CostasRosalinda C Roberts
May 10, 2006·Biological Psychiatry·Hidehiko TakahashiTetsuya Suhara
Apr 8, 2003·Biological Psychiatry·Tsutomu TakahashiMasayoshi Kurachi
Jul 25, 2006·NeuroImage·Laurie McCormickMichael Brumm
Sep 20, 2005·Schizophrenia Research·Laurie McCormickNancy Andreasen
Jul 26, 2005·Progress in Neuro-psychopharmacology & Biological Psychiatry·Akihiro TakanoTsukasa Koyama
May 22, 2016·Biological Psychiatry·Jodi J WeinsteinAnissa Abi-Dargham
Apr 28, 2005·Psychiatry Research·Fumihiko YasunoMakoto Inoue
Mar 18, 2004·Neuroimaging Clinics of North America·David ErritzoeAnissa Abi-Dargham
Jun 2, 2006·Journal of Abnormal Psychology·Sarah E MorrisKeith H Nuechterlein
Dec 6, 2008·Schizophrenia Research·Shoko NozakiTetsuya Suhara
Apr 6, 2013·Medical Hypotheses·Arnold E Eggers
May 6, 2009·International Journal of Psychophysiology : Official Journal of the International Organization of Psychophysiology·Daniel H MathalonJudith M Ford
Feb 18, 2012·The International Journal of Neuropsychopharmacology·Birgitte FagerlundBirte Y Glenthøj
Jun 18, 2016·The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry·Andrea SchmittWFSBP Task Force on Biological Markers
Sep 12, 2003·Trends in Pharmacological Sciences·Clare BergsonMichael S Lidow
Aug 22, 2014·Journal of Medicinal Chemistry·Markus PielFrank Rösch
Oct 10, 2007·Harvard Review of Psychiatry·W Gordon Frankle
Dec 9, 2017·International Review of Psychiatry·Christin SchifaniRomina Mizrahi
Nov 9, 2018·The Journal of Comparative Neurology·Ellen R CullityJee Hyun Kim
Jun 20, 2006·European Archives of Psychiatry and Clinical Neuroscience·H TuppurainenJ Tiihonen
Apr 21, 2005·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Hideo TsukadaEdward F Domino
Apr 28, 2005·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Hideo TsukadaEdward F Domino
Oct 24, 2009·European Archives of Psychiatry and Clinical Neuroscience·Ryosuke ArakawaTetsuya Suhara
Oct 21, 2005·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Patrizia RiccardiRobert Kessler
Oct 21, 2005·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Gerhard GründerPeter Bartenstein
Aug 24, 2019·Brain Structure & Function·Jonas A HospM Reisert
Sep 26, 2019·The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry·Serge A MitelmanDouglas S Lehrer
Jun 24, 2017·European Psychiatry : the Journal of the Association of European Psychiatrists·R AbboudV A Diwadkar
May 27, 2020·Journal of Neural Transmission·Ken YonezawaHiroki Ozawa
Sep 15, 2006·Nihon yakurigaku zasshi. Folia pharmacologica Japonica·Akihiro Takano, Tetsuya Suhara

Related Concepts

FLB 457, hydrobromide, (S)-isomer
Functional Cerebral Localization
Cingulate Cortex
Factor Construct Rating Scales (Fcrs)
Schizophrenic Psychology
Tomography, Emission-Computed
Dopamine D2 Receptor

Trending Feeds


Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Synthetic Genetic Array Analysis

Synthetic genetic arrays allow the systematic examination of genetic interactions. Here is the latest research focusing on synthetic genetic arrays and their analyses.

Congenital Hyperinsulinism

Congenital hyperinsulinism is caused by genetic mutations resulting in excess insulin secretion from beta cells of the pancreas. Here is the latest research.

Neural Activity: Imaging

Imaging of neural activity in vivo has developed rapidly recently with the advancement of fluorescence microscopy, including new applications using miniaturized microscopes (miniscopes). This feed follows the progress in this growing field.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Epigenetic Memory

Epigenetic memory refers to the heritable genetic changes that are not explained by the DNA sequence. Find the latest research on epigenetic memory here.

Cell Atlas of the Human Eye

Constructing a cell atlas of the human eye will require transcriptomic and histologic analysis over the lifespan. This understanding will aid in the study of development and disease. Find the latest research pertaining to the Cell Atlas of the Human Eye here.

Femoral Neoplasms

Femoral Neoplasms are bone tumors that arise in the femur. Discover the latest research on femoral neoplasms here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.